Clinical Drug Experience Knowledgebase

Hodgkin Disease

Lymphoma, Large-Cell, Anaplastic

Adenocarcinoma (Phase 3)

Anemia, Refractory (Phase 2)

Anemia, Refractory, with Excess of Blasts (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Burkitt Lymphoma (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 1)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Central Nervous System Diseases (Phase 2)

Cholangiocarcinoma (Phase 1)

Colorectal Neoplasms (Phase 2)

Disease (Phase 2)

Epstein-Barr Virus Infections (Phase 2)

Esophageal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Gastrointestinal Neoplasms (Phase 1)

Graft vs Host Disease (Phase 1)

Head and Neck Neoplasms (Phase 1)

Hematologic Diseases (Phase 2)

Hodgkin Disease (Phase 4)

Immunoblastic Lymphadenopathy (Phase 2)

Intraocular Lymphoma (Phase 2)

Leukemia (Phase 3)

Leukemia, Hairy Cell (Phase 2)

Leukemia, Large Granular Lymphocytic (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia-Lymphoma, Adult T-Cell (Phase 2)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myelomonocytic, Chronic (Phase 1)

Leukemia, Myelomonocytic, Juvenile (Phase 1)

Leukemia, Promyelocytic, Acute (Phase 1)

Leukemia, T-Cell (Phase 2)

Lung Neoplasms (Phase 2)

Lupus Erythematosus, Systemic (Phase 2)

Lymphatic Diseases (Phase 2)

Lymphoma (Phase 4)

Lymphoma, B-Cell (Phase 3)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Extranodal NK-T-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Anaplastic (Phase 3)

Lymphoma, Large-Cell, Immunoblastic (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 3)

Lymphoma, T-Cell (Phase 3)

Lymphoma, T-Cell, Cutaneous (Phase 3)

Lymphoma, T-Cell, Peripheral (Phase 3)

Lymphomatoid Granulomatosis (Phase 2)

Lymphomatoid Papulosis (Phase 2)

Lymphoproliferative Disorders (Phase 2)

Mesothelioma (Phase 2)

Multiple Myeloma (Phase 1)

Mycoses (Phase 3)

Mycosis Fungoides (Phase 3)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 1)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Neoplasms, Squamous Cell (Phase 1)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Pelvic Neoplasms (Phase 2)

Plasmablastic Lymphoma (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 2)

Prostatic Neoplasms (Phase 2)

Sarcoma (Phase 1)

Sarcoma, Kaposi (Phase 2)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Systemic (Phase 2)

Sclerosis (Phase 2)

Sezary Syndrome (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 1)

Syndrome (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Ureteral Neoplasms (Phase 3)

Urethral Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Urologic Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Uterine Neoplasms (Phase 2)

Waldenstrom Macroglobulinemia (Phase 2)